Dicarboxylic acids and derivatives
Dilauroyl peroxide, 97%
CAS: 105-74-8 Molecular Formula: C24H46O4 Molecular Weight (g/mol): 398.628 MDL Number: MFCD00008964 InChI Key: YIVJZNGAASQVEM-UHFFFAOYSA-N Synonym: lauroyl peroxide,dilauroyl peroxide,dodecanoyl peroxide,peroxide, bis 1-oxododecyl,laurydol,laurox,alperox c,dodecanoic peroxyanhydride,dyp-97f,peroxyde de lauroyle PubChem CID: 7773 ChEBI: CHEBI:82479 IUPAC Name: dodecanoyl dodecaneperoxoate SMILES: CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC
Dilauroyl peroxide, 99%
CAS: 105-74-8 Molecular Formula: C24H46O4 Molecular Weight (g/mol): 398.63 MDL Number: MFCD00008964 InChI Key: YIVJZNGAASQVEM-UHFFFAOYSA-N Synonym: lauroyl peroxide,dilauroyl peroxide,dodecanoyl peroxide,peroxide, bis 1-oxododecyl,laurydol,laurox,alperox c,dodecanoic peroxyanhydride,dyp-97f,peroxyde de lauroyle PubChem CID: 7773 ChEBI: CHEBI:82479 IUPAC Name: dodecanoyl dodecaneperoxoate SMILES: CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC
Diethyl 2,2'-Thiodiglycolate 97.0+%, TCI America™
CAS: 925-47-3 Molecular Formula: C8H14O4S Molecular Weight (g/mol): 206.256 MDL Number: MFCD00087932 InChI Key: TVCSSJHLVLMADJ-UHFFFAOYSA-N Synonym: 2,2′C-Thiodiglycolic Acid Diethyl Ester, Diethyl 2,2′C-Thiodiacetate, 2,2′C-Thiodiacetic Acid Diethyl Ester PubChem CID: 70216 IUPAC Name: ethyl 2-(2-ethoxy-2-oxoethyl)sulfanylacetate SMILES: CCOC(=O)CSCC(=O)OCC
Sigma Aldrich Luperox™ TBEC, tert-Butylperoxy 2-ethylhexyl carbonate
MilliporeSigma Sigma Organics products encompass a wide range of quality reagents, solvents, catalysts, and building blocks for organic synthesis. From benchtop discovery to process development and scale-up, Sigma Organics solutions are built to meet the needs of synthetic chemists.
Sigma Aldrich Luperox™ A75, Benzoyl peroxide
MilliporeSigma Sigma Organics products encompass a wide range of quality reagents, solvents, catalysts, and building blocks for organic synthesis. From benchtop discovery to process development and scale-up, Sigma Organics solutions are built to meet the needs of synthetic chemists.
Sigma Aldrich Luperox™ LP, Lauroyl peroxide
MilliporeSigma Sigma Organics products encompass a wide range of quality reagents, solvents, catalysts, and building blocks for organic synthesis. From benchtop discovery to process development and scale-up, Sigma Organics solutions are built to meet the needs of synthetic chemists.
Selleck Chemical LLC CUDC-101 S1194-10mM/1mL
CUDC-101 is a potent multi-targeted inhibitor against HDAC EGFR and HER2 with IC50 of 4 4 nM 2 4 nM and 15 7 nM and inhibits class I/II HDACs but not class III Sir-type HDACs Phase 1
Medchemexpress LLC Lei 101 hydrochloride | 2250025-91-1 | 99.4% | 508.99 g/mol | C23H26ClFN4O4S | 10MM 1ML
LEI-101 hydrochloride is a potent, selective, orally bioavailable cannabinoid CB2 receptor agonist used for receptor pharmacology and preclinical research. It is provided in both solid form and as a ready-to-use DMSO solution to support biochemical and cellular assays.
Medchemexpress LLC Ucf-101 | 313649-08-0 | 99.7% | 495.51 g/mol | C27H17N3O5S | 10MM 1ML
Ucf-101 is a selective, competitive inhibitor of the pro-apoptotic serine protease Omi/HtrA2, supplied as a 10 mM solution in DMSO for research use. It inhibits His-Omi with IC50 = 9.5 μM, shows minimal activity against other serine proteases, and is provided with analytical documentation for quality and safety.
![Medchemexpress LLC L-Leucinamide, N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]- | 110044-82-1 | ≥98.0% | 383.53 | 100 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000385191-logo.png-250.jpg){kind=logo}
Medchemexpress LLC L-Leucinamide, N-acetyl-L-leucyl-N-[(1S)-1-formylpentyl]- | 110044-82-1 | ≥98.0% | 383.53 | 100 MG
MG-101 (ALLN) is an inhibitor of cysteine proteases, specifically inhibiting calpain I, calpain II, cathepsin B, and cathepsin L with Kis of 190, 220, 150, and 500 pM, respectively. It induces apoptosis and inhibits tumor growth, making it suitable for research on colon cancer. For research use only.
- Inhibits cysteine proteases: calpain I, calpain II, cathepsin B, and cathepsin L
- Induces apoptosis
- Inhibits tumor growth
- Can be used for colon cancer research
Medchemexpress LLC Lei-101 | 2250025-91-1 | 99.4% | 508.99 g·mol⁻¹ | C23H26ClFN4O4S | 10MG
LEI-101 is a potent, selective, orally bioavailable cannabinoid CB2 receptor agonist used in research to investigate CB2-mediated signaling and pharmacology. It exhibits approximately 100-fold selectivity for CB2 over CB1, with a pEC50 of about 8 for human CB2, low hERG affinity, and is supplied as a high-purity white to off-white solid suitable for in vitro and in vivo studies.
- High purity (99.4%).
- Potent CB2 agonist (pEC50 ≈ 8 for hCB2).
- Approximately 100-fold selectivity for CB2 over CB1.
- Low hERG binding (pKi < 4).
- Soluble in DMSO (≈116.67 mg/mL).
- Stable when stored sealed and kept away from moisture; in solvent: -80°C (6 months), -20°C (1 month).
- Provided in milligram-scale quantities for research use.
Medchemexpress LLC Urea, N-[1-[(2-amino-4-pyridinyl)methyl]-1H-indol-4-yl]-N'-(5-bromo-2-methoxyphenyl)- | 900573-88-8 | 99.0% | 466.33 | 1 ML
JI-101 is an orally available multi-kinase inhibitor that targets VEGFR2, PDGFRβ, and EphB4. It exhibits potent anti-cancer activity and has been studied for its pharmacokinetics and tissue distribution. The compound is stable in preclinical and human liver microsomes, with relatively higher metabolism in mice compared to dog, human, and rat liver microsomes. Following oral administration, JI-101 is rapidly absorbed, reaching peak concentration within 2 hours, and has an oral bioavailability of 55%. Its primary elimination route is through feces, and it undergoes extensive tissue distribution, with preferential uptake into lung tissue.
- Orally available
- Multi-kinase inhibitor, targeting VEGFR2, PDGFRβ, and EphB4
- Potent anti-cancer activity
- Stable in preclinical and human liver microsomes
- Rapidly absorbed after oral administration
- Extensive tissue distribution, with preferred uptake in lung tissue
Medchemexpress LLC JI-101 | 900573-88-8 | 99.0% | 466.33 | 5 MG
JI-101 is an orally available multi-kinase inhibitor of VEGFR2, PDGFRβ, and EphB4 with potent anti-cancer activity. It is for research use only and is not sold to patients.
- Orally available multi-kinase inhibitor.
- Inhibits VEGFR2, PDGFRβ, and EphB4.
- Potent anti-cancer activity.
- Stable in all preclinical and human liver microsomes.
- Rapidly absorbed after oral administration, reaching Cmax within 2 hours.
- Extensive tissue distribution with rapid and preferred uptake into lung tissue.
- Oral bioavailability is 55%.
- Primary route of elimination is feces.